Evidence map›Paper›PMID 31617404›Full record

ArticleCartilage2021

Fresh Osteochondral Allograft Transplantation in the Knee: A Viability and Histologic Analysis for Optimizing Graft Viability and Expanding Existing Standard Processed Graft Resources Using a Living Donor Cartilage Program.

Mario Hevesi, Janet M Denbeigh, Carlo A Paggi, Catalina Galeano-Garces, Leila Bagheri, A Noelle Larson, Michael J Stuart, Daniel B F Saris, Andre J van Wijnen, Aaron J Krych

Open access · bronzeAbstract read
In one paragraph

Article in Cartilage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Mario HevesiDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Janet M DenbeighDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Carlo A PaggiDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Catalina Galeano-GarcesDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Leila BagheriDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
A Noelle LarsonDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Michael J StuartDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Daniel B F SarisDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Andre J van WijnenDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5882-709X
Aaron J KrychDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-3248-8007
Mayo Clinic in Arizona · USUniversity Medical Center Utrecht · NL

Funding

Genetic Risk Factors for PsoriasisR01AR049049 · NIAMS · WASHINGTON UNIVERSITY · PI BOWCOCK, ANNE MARY · 2003 to 2006
$1.4M
NIAMS NIH HHS R01 AR049049
6 · The paper itself

Abstract

objectiveThis study aims to (1) determine and validate living cartilage allograft transplantation as a novel source for viable osteochondral allograft (OCA) tissues and (2) perform histologic and viability comparisons of living donor cartilage tissues to currently available clinical-grade standard processed grafts.

designUsing healthy cartilage from well-preserved contralateral compartments in 27 patients undergoing total knee arthroplasty (TKA) and 10 clinical-grade OCA specimens obtained immediately following operative implantation, standard and living donor OCA quality was evaluated at the time of harvest and following up to 3 weeks of storage on the basis of macroscopic International Cartilage Repair Society grade, histology, and viability.

resultsOsteochondral samples demonstrated a consistent decrease in viability and histologic quality over the first 3 weeks of storage at 37°C, supporting the utility of an OCA paradigm shift toward early implantation, as was the clinical standard up until recent adoption of transplantation at 14 to 35 days following donor procurement. Samples from the 10 clinical-grade OCAs, implanted at an average of 23 days following graft harvest demonstrated a mean viable cell density of 45.6% at implantation, significantly lower (

conclusionsOsteochondral tissue viability and histologic quality progressively decreases with

Indexed as

Living DonorsTissue PreservationAllograftsCartilageChondrocytesHumansKnee JointTissue and Organ HarvestingTransplantation, Homologousjoint preservationliving donorosteochondral allograftviability

Identifiers

PMID31617404
PMCPMC8808912
OpenAlexW2980831853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.